The R&D center of Hebei Kaiwei Hengcheng Co., Ltd. possesses the following professional characteristics: it specializes in the research and development of specialized hospital drugs and equipment, and has long emphasized the development of sterile products.
- Quick response: Expert in generic drug development and first-generic drug development, ensuring products are first to market through our proprietary platform (a high-end R&D platform covering major European and American countries) and international registration advantages.
- Focusing on advantages: Leverage the combined strengths and meticulously cultivate in specialized fields.
- Internationalization orientation: Adopting an international top-level design to align product development, production quality management systems, and marketing with international standards. Its flagship products cover major global pharmaceutical markets. The R&D strategy can be summarized as "R&D in one location, application in three locations", while the channel strategy is reflected as "production in one factory, global sales".
Adhering to the corporate philosophy of "Virtue supports great undertakings, and self-cultivation fosters excellence", our company focuses on product research and development, controls product quality from the source, and strives continuously to develop high-quality innovative and generic drugs globally.
By continuously embracing challenges and investing heavily in drug research and development, Kaiwei will gradually evolve into a medium-sized innovative pharmaceutical and healthcare enterprise with a certain international reputation, caring for every global user who uses Kaiwei's medicines with utmost sincerity and love.
